Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of acquired drug resistance mutations in antiretroviral- experiencing subjects from 2012 to 2017 in Hunan Province of central South China.

Virology journal - 17 Mar 2020

Zou Xiaobai, He Jianmei, Zheng Jun, Malmgren Roberta, Li Weisi, Wei Xiuqing, Zhang Guoqiang, Chen Xi

Abstract excerpt

BACKGROUND: There are few data on the prevalence of acquired drug resistance mutations (ADRs) in Hunan Province, China, that could affect the effectiveness of antiretroviral therapy (ART). OBJECTIVES: The main objectives of this study were to determine the prevalence of acquired drug resistance (ADR) the epidemic characteristics of HIV-1-resistant strains among ART-failed HIV patients in Hunan Province, China....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to CD4 Lymphocyte Count

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to HIV Infections

Share to Prevalence

Share to Treatment Failure

Source

Open in PubMed Open full text

Identifiers

PMID: 32183889
DOI: 10.1186/s12985-020-01311-3
PMCID: PMC7079350

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of acquired drug resistance mutations in antiretroviral- experiencing subjects from 2012 to 2017 in Hunan Province of central South China.PMID 32183889Read ↗

Pre-treatment and acquired HIV drug resistance in Hunan: a cross-sectional analysis of a growing challenge.Semantic proximity Read ↗

Prevalence of Primary Drug Resistance Among Newly Diagnosed HIV-1-Infected Individuals in Hunan Province, China.Semantic proximity Read ↗

Characterization of HIV-1 subtypes and drug resistance mutations in Henan Province, China (2017-2019).Semantic proximity Read ↗

Exploring disparities in HIV-1 pretreatment and acquired drug resistance in China from 2003 to 2022.Semantic proximity Read ↗

Genotypes and transmitted drug resistance among treatment-naive HIV-1-infected patients in a northwestern province, China: trends from 2003 to 2013.Semantic proximity Read ↗

[Survey of HIV-1 drug resistance threshold in Shandong Province in 2013-2015].Semantic proximity Read ↗

HIV-1 Drug Resistance Mutations among Antiretroviral Drug-Experienced Patients in the South of IranSemantic proximity Read ↗

Survey of Pretreatment HIV Drug Resistance and Genetic Transmission Network Analysis Among HIV Patients in a High Drug-Use Area of Southwest China.Semantic proximity Read ↗

Distribution characteristics of drug resistance mutations of HIV CRF01_AE, CRF07_BC and CRF08_BC from patients under ART in Ganzhou, China.Semantic proximity Read ↗

HIV-1 Drug Resistance, Distribution of Subtypes, and Drug Resistance-Associated Mutations in Virologic Failure Individuals in Chengdu, Southwest China, 2014-2016.Semantic proximity Read ↗

Changing Proportions of HIV-1 Subtypes and Transmitted Drug Resistance Among Newly Diagnosed HIV/AIDS Individuals — China, 2015 and 2018Semantic proximity Read ↗

[Drug resistance mutations and its associated factors among 579 HIV/AIDS patients experiencing failure of antiretroviral therapy in Jiangsu Province, China].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.